Literature DB >> 24452665

Temporal decrease in overall antibiotic consumption accompanying antibiotic prescribing rate disclosure policy: evidence from analysis of national health insurance claims data in South Korea.

Young Sook Lee1, Jin Won Kwon, Ock Hee Oh, Hyun Soon Sohn.   

Abstract

The health insurance review and assessment services, responsible for the assessment of quality and quantity of healthcare providers' services, implemented a public disclosure policy for antibiotic prescribing rate in February 2006. The aim of this study was to investigate changes of overall antibiotic consumption following the policy by analysing national healthcare utilization data from 2005 to 2009. Prescription information of systemic antibiotics excluding antifungals and topical antibiotics was retrospectively collected from the population-based health insurance claims sample data for the five years from 2005 to 2009. Those data were analysed using the standardised anatomical therapeutic chemical/defined daily dose method. Antibiotic consumption was standardised by the defined daily dose per 1,000 inhabitants per day (DID). Descriptive statistics was used to present consumption figures for every year. Secondary comparison to other OECD countries based on published reports was added to weigh the antibiotic consumption level of South Korea in a global perspective. Overall antibiotic consumption decreased in 2006 (23.8 DID, 3.6 % decrease from 24.7 DID in 2005) and 2007 (21.5 DID, 9.7 % decrease from 2006), but rebounded in 2008 (24.3 DID, 13 % increase from 2007) and 2009 (25.2 DID, 3.7 % increase from 2008). Temporal decreases in 2006 and 2007 were attributed to fewer prescriptions of penicillins (J01C group), among which the decrease in amoxicillin consumption was almost equal to that of overall antibiotic consumption. A similar fluctuation trend in overall antibiotic consumption occurred in the out-patient setting rather than the in-patient setting. Amoxicillin decreased since 2007, while amoxicillin/clavulanic acid, cefaclor and clarithromycin increased without dropping. The estimated antibiotic consumption level in this study was higher than the average of OECD countries, and the yearly fluctuation shown during the five years was a country specific pattern observed only in South Korea. Overall antibiotic consumption was temporarily decreased in 2006 and 2007. But this result might not signify an effect of government policy of antibiotic prescribing rate disclosure to the public. The results presented in DID unit, a more objective index than prescribing rates, suggest the need for further strategies to reduce antibiotic use nationwide.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24452665     DOI: 10.1007/s12272-014-0333-5

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  5 in total

1.  Antibiotic use in South Korea from 2007 to 2014: A health insurance database-generated time series analysis.

Authors:  Juhee Park; Euna Han; Soo Ok Lee; Dong-Sook Kim
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

2.  Pediatric fluoroquinolone prescription in South Korea before and after a regulatory intervention: A nationwide study, 2007-2015.

Authors:  Seung Yeon Song; Joo Hee Shin; Su Yeong Hyeon; Donguk Kim; Won Ku Kang; Soo-Han Choi; Yae-Jean Kim; Eun Young Kim
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

Review 3.  Antibiotic Control Policies in South Korea, 2000-2013.

Authors:  Baek Nam Kim; Hong Bin Kim; Myoung Don Oh
Journal:  Infect Chemother       Date:  2016-09

4.  Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map.

Authors:  Susan Rogers Van Katwyk; Jeremy M Grimshaw; Miriam Nkangu; Ranjana Nagi; Marc Mendelson; Monica Taljaard; Steven J Hoffman
Journal:  PLoS Med       Date:  2019-06-11       Impact factor: 11.069

5.  Signal Detection of Adverse Drug Reaction of Amoxicillin Using the Korea Adverse Event Reporting System Database.

Authors:  Mick Soukavong; Jungmee Kim; Kyounghoon Park; Bo Ram Yang; Joongyub Lee; Xue Mei Jin; Byung Joo Park
Journal:  J Korean Med Sci       Date:  2016-09       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.